Supernus Pharmaceuticals
SUPN
#4182
Rank
C$3.61 B
Marketcap
C$63.11
Share price
1.29%
Change (1 day)
21.67%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of September 2025 : C$0.38 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has C$0.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.65 B92.55%
2023-12-31C$0.33 B-46%
2022-12-31C$0.62 B44.61%
2021-12-31C$0.43 B-19.65%
2020-12-31C$0.53 B18.85%
2019-12-31C$0.45 B-6.53%
2018-12-31C$0.48 B175.45%
2017-12-31C$0.17 B45.38%
2016-12-31C$0.12 B40.38%
2015-12-31C$86.26 M0.01%
2014-12-31C$86.26 M-1.4%
2013-12-31C$87.49 M-0.59%
2012-12-31C$88.01 M78.24%
2011-12-31C$49.37 M51.05%
2010-12-31C$32.69 M-53.3%
2009-12-31C$69.99 M-4.66%
2008-12-31C$73.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
C$3.82 B 884.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$13.69 B 3,425.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$22.79 B 5,769.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.68 B 2,650.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$25.64 B 6,501.93%๐Ÿ‡บ๐Ÿ‡ธ USA